ARE, antioxidant response element
337 Although all cell types responded to this inhibitor in vitro and showed promising therapeutic effects in vivo, 337 phase I clinical trials for treating advanced solid tumors ultimately failed due to cardiovascular toxicity and wide variability in patient responses
therefore, they do not interact with conventional medication in the same way that herbal medicine or other nutraceuticals do
Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction
Wang H, Zong Y, Han Y, Zhao J, Liu H, Liu Y
Additionally, refrain from strenuous exercise and invasive skincare treatments for a short period, and follow your doctor's specific instructions for optimal outcomes